[
  {
    "date": "2023-12-30",
    "symbol": "DRMAW",
    "period": "FY",
    "entityregistrantname": "DERMATA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1853816,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "2023-12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "entityextransitionperiod": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityfilenumber": "001-40739",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "86-3218736",
    "entityaddressaddressline1": "3525 Del Mar Heights Rd.",
    "entityaddressaddressline2": 322,
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 659,
    "localphonenumber": "800-2543",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "DRMA",
    "securityexchangename": "NASDAQ",
    "auditorname": "Moss Adams LLP",
    "auditorlocation": "San Diego, California",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 7438135,
    "prepaidexpenseandotherassetscurrent": 540499,
    "assets": 7978634,
    "accountspayablecurrent": 866028,
    "accruedliabilitiesandotherliabilities": 757588,
    "liabilities": 1623616,
    "commonstockvalue": 393,
    "additionalpaidincapital": 59742503,
    "retainedearningsaccumulateddeficit": -53387878,
    "stockholdersequity": 6355018,
    "liabilitiesandstockholdersequity": 7978634,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 250000000,
    "commonstocksharesissued": 3930840,
    "commonstocksharesoutstanding": 3930840,
    "researchanddevelopmentexpense": 4069766,
    "generalandadministrativeexpense": 3972140,
    "operatingexpenses": 8041906,
    "operatingincomeloss": -8041906,
    "interestincomeother": 247216,
    "netincomeloss": -7794690,
    "earningpersharebasicanddiluted": -2.67,
    "weightedaveragebasicanddilutedcommonunitsshares": 2924398,
    "sharesissued": 3930840,
    "stockissuedduringperiodsharesnewissues": 543555,
    "stockissuedduringperiodvaluenewissues": 55,
    "issuanceofcommonstockuponexerciseofprefundedwarrantsshares": 1875445,
    "issuanceofcommonstockuponexerciseofprefundedwarrantsamount": 187,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 522082,
    "issuanceofcommonstockuponexerciseofwarrantsnetofissuancecostsshares": 742095,
    "issuanceofcommonstockuponexerciseofwarrantsnetofissuancecostsamount": 74,
    "settlementoffractionalsharespaidincashshares": -370,
    "settlementoffractionalsharespaidincashamount": -40,
    "sharebasedcompensation": 522082,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -162695,
    "increasedecreaseinaccountspayable": 369326,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 331656,
    "adjustmentstoreconcilenetincomelosstocashprovidedbyusedinoperatingactivities": 1385759,
    "netcashprovidedbyusedinoperatingactivities": -6408931,
    "proceedsfromissuanceofcommonstock": 7605625,
    "proceedsfromwarrantexercises": 187,
    "paymentforfractionalsharesinreversestocksplit": 40,
    "netcashprovidedbyusedinfinancingactivities": 7605772,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 1196841,
    "incometaxespaid": 950,
    "fairvalueadjustmentofwarrants": 144765,
    "incrementalfairvalueofwarrantinducement": 2995343,
    "accumulateddeficit": -53400000,
    "restrictedcashequivalents": 7400000,
    "netcashprovidedbyusedincontinuingoperations": -6400000,
    "earningspersharebasic": -2.67,
    "weightedaveragenumberofbasicanddilutedsharesoutstanding": 2924398,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 102074,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8460771,
    "prepaidinsurance": 426413,
    "prepaidexpenseandotherassets": 91232,
    "prepaidrent": 14498,
    "interestreceivable": 8356,
    "accruedresearchanddevelopmentcostscurrent": 40596,
    "employeerelatedliabilitiescurrent": 716490,
    "otheraccruedliabilities": 502,
    "otheraccruedliabilitiescurrent": 757588,
    "classofwarrantorrightoutstanding": 250000000,
    "temporaryequitysharesauthorized": 2730000,
    "temporaryequitysharessubscribedbutunissued": 513277,
    "temporaryequitysharesoutstanding": 3930840,
    "temporaryequitysharesissued": 3930840,
    "deferredcompensationarrangementwithindividualexerciseprice": 328,
    "warrantsexpirationdate": "11/15/2026",
    "fairvaluepershare": 0.61,
    "warrantreduceddescription": "from $21.20 to $2.82 per share upon closing of the March 2023 Offering",
    "preferredstocksharesauthorized": 10000000,
    "warrantsexpiredate": "April 2022",
    "preferredstocknoparvalue": 0.0001,
    "descriptionofabeyanceshares": "the Holder left 2,730,000 shares in abeyance at the Company’s transfer agent to be delivered to the Holder at their request. The 2,730,000 shares held in abeyance were delivered to the Holder on January 8, 2024. Accordingly, as of December 31, 2023, 2,730,000 shares were held in abeyance, have not been issued and are not outstanding",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.039,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.12,
    "otherresearchanddevelopmentexpense": 193700,
    "othergeneralandadministrativeexpense": 328382,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 63.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 36091,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 53413,
    "weightedaverageexercisepricebeginningbalance": 60.32,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 40.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y9M18D",
    "weightedaverageremainingcontractualtermsinyearsoptionsgranted": "P9Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y3M18D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y9M18D",
    "commonstockcapitalsharesreservedforfutureissuance": 513277,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 600000,
    "stockawardsgrantedvestingperiod": "four years for employees and one year for directors of the Company’s Board and consultants",
    "commonstocktradedprice": 0.61,
    "commonstockauthorizedforissuance": 513150,
    "commonstockauthorizedforissuanceincrease": 629069,
    "descriptionrelatedtoagreementpayment": "the Company was required to make future milestone payments to Villani in an aggregate amount of up to $20.25 million upon the achievement of specified development and sales milestones, payable in cash or in equity",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1637000,
    "incometaxreconciliationpermanentandotherdifference": 55000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 86000,
    "incometaxreconciliationtaxcreditsresearch": -259000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1755000,
    "deferredtaxassetsoperatinglosscarryforwards": 2980000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 596000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 1508000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 246000,
    "deferredtaxassetsgoodwillandintangibleassets": 5000,
    "deferredtaxassetsother": 129000,
    "deferredtaxassetsgross": 5464000,
    "deferredtaxassetsvaluationallowance": 5464000,
    "unrecognizedtaxbenefits": 645000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 64000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 24000,
    "valuationallowance": 5500000,
    "operatinglosscarryforwards": 5000000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 14200000,
    "netoperatinglosscarryforwardstaxableincomeoffsetlimitpercentage": 0.8,
    "taxcreditcarryforwardexpirationyear": 2041,
    "sharesoutstanding": 101465,
    "commonunitauthorized": 102074
  },
  {
    "date": "2022-12-30",
    "symbol": "DRMAW",
    "period": "FY",
    "entityregistrantname": "DERMATA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1853816,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2022",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "entityextransitionperiod": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40739",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "86-3218736",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "entityaddressaddressline1": "3525 Del Mar Heights Rd",
    "entityaddressaddressline2": 322,
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "800-2543",
    "security12btitle": "Warrants, exercisable for one share of Common Stock",
    "tradingsymbol": "DRMAW",
    "securityexchangename": "Nasdaq",
    "auditorname": "Mayer Hoffman McCann, P.C.",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 199,
    "cashandcashequivalentsatcarryingvalue": "null",
    "prepaidexpenseandotherassetscurrent": 703194,
    "assets": "null",
    "accountspayablecurrent": 496702,
    "otheraccruedliabilitiescurrent": 756,
    "liabilities": 922634,
    "commonstockvalue": 1232,
    "additionalpaidincapital": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": "null",
    "generalandadministrativeexpense": "null",
    "operatingcostsandexpenses": "null",
    "operatingincomeloss": "-null",
    "interestincomeexpensenet": 63573,
    "netincomeloss": "-null",
    "netincomelossavailabletocommonstockholdersbasic": "-null",
    "earningspersharebasic": -0.87,
    "weightedaveragebasicanddilutedcommonunitsshares": "null",
    "sharesissued": "null",
    "issuanceofcommonstockandwarrantsnetissuancecostsshares": 898585,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": "null",
    "issuanceofcommonstockandwarrantsnetofissuancecostsamount": "null",
    "issuanceofcommonstockuponexerciseofprefundedwarrantsshares": "null",
    "issuanceofcommonstockuponexerciseofprefundedwarrantsamount": 287,
    "issuanceofrestrictedstockunitawardsamount": 166875,
    "issuanceofcommonstockuponconversionofrestrictedstockunitsshares": 219634,
    "issuanceofcommonstockuponconversionofrestrictedstockunitsamount": -22,
    "sharebasedcompensation": 200000,
    "increasedecreaseinprepaidexpense": -121940,
    "increasedecreaseinaccountspayable": -18543,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -256973,
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "proceedsfromissuanceofcommonstock": "null",
    "proceedsfromissuancesofcommonstockuponexercisesofprefundedwarrants": 287,
    "netcashprovidedbyusedinfinancingactivities": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": "-null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": "null",
    "incometaxespaid": 950,
    "accumulateddeficit": -45600000,
    "restrictedcashequivalents": 6200000,
    "netcashprovidedbyusedincontinuingoperations": 8800000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 7,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "commonstockoptions": "null",
    "commonstockwarrants": "null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "prepaidinsurance": 586407,
    "prepaidexpenseandotherassets": 92581,
    "prepaidrent": 11604,
    "interestreceivable": 12602,
    "prepaidexpensecurrent": 703194,
    "accruedresearchanddevelopmentcosts": 254787,
    "employeerelatedliabilitiescurrent": 170389,
    "otheraccruedliabilitiesnoncurrent": 425932,
    "commonstockshareissued": "null",
    "netconsideration": "null",
    "authorizedcommonstockshares": "null",
    "warrantsexpiredate": "August 17, 2026",
    "fairvalueexercisepricepershare": 0.409,
    "pipecommonstockconversionofstocksharesissued": "null",
    "commonstocksharessold": 898585,
    "prefundedwarrant": "null",
    "prefundedwarrantoutstanding": "null",
    "warrantssoldtopurchaseoneshareofcommonstock": "null",
    "warrantssoldtopurchaseoneshareofcommonstockexerciseprice": 1.325,
    "classofwarrantorrightoutstanding": 69212,
    "exercisablewarrantoutstanding": 69212,
    "warrantsexerciseprice": 7,
    "warrantssoldtopurchaseshareofcommonstock": 128571,
    "warrantssoldtopurchaseshareofcommonstockexerciseprice": 8.05,
    "warrantoutstanding": "null",
    "exercisepricepershare": 1.325,
    "debtconversionconvertedinstrumentamount1": 2300000,
    "dividendspreferredstockstock": 269038,
    "percentagesofinitialpublicpershareofferingprice": 0.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.015,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": 5.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.23,
    "otherresearchanddevelopmentexpense": 218324,
    "othergeneralandadministrativeexpense": 712001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 533127,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 617769,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 4.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 8.3,
    "weightedaverageremainingcontractualtermsinyearsoptionsgranted": 8.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 219634,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionssettled": 219634,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 900000,
    "weightedaverageremainingcontractualterminyears": 2.4,
    "commonstockcapitalsharesreservedforfutureissuance": 455539,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "stockawardsgrantedvestingperiod": "four years for employees and one year for directors of the Company’s board and consultants",
    "commonstocktradedprice": 0.409,
    "compensationforservices": 219634,
    "dividendspreferredstock": 1200000,
    "convertiblepreferredstockconvertedtoothersecurities": "null",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -2018,
    "incometaxreconciliationpermanentandotherdifference": 68,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 89,
    "incometaxreconciliationtaxcreditsresearch": -219,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 2080,
    "deferredtaxassetsoperatinglosscarryforwards": 1927,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 400000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 1068,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 311,
    "deferredtaxassetsgoodwillandintangibleassets": 49,
    "deferredtaxassetsother": 17,
    "deferredtaxassetsgross": 3709,
    "deferredtaxassetsvaluationallowance": 3709,
    "unrecognizedtaxbenefits": 557,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 81,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 435,
    "valuationallowance": 370000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 9200000,
    "netoperatinglosscarryforwardstaxableincomeoffsetlimitpercentage": 0.8,
    "taxcreditcarryforwardexpirationyear": 2041
  },
  {
    "date": "2021-12-30",
    "symbol": "DRMAW",
    "period": "FY",
    "entityregistrantname": "DERMATA THERAPEUTICS, INC.",
    "entitycentralindexkey": 1853816,
    "documenttype": "10-K",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2021",
    "entityfilercategory": "Non-accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "entityextransitionperiod": "true",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40739",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "82-1510982",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "entityaddressaddressline1": "3525 Del Mar Heights Rd",
    "entityaddressaddressline2": 322,
    "entityaddresscityortown": "San Diego",
    "entityaddresspostalzipcode": 92130,
    "cityareacode": 858,
    "localphonenumber": "800-2543",
    "security12btitle": "Common Stock Purchase Warrants",
    "tradingsymbol": "DRMAW",
    "securityexchangename": "Nasdaq",
    "entityaddressstateorprovince": "CA",
    "auditorname": "Mayer Hoffman McCann, P.C.",
    "auditorlocation": "San Diego, California",
    "auditorfirmid": 199,
    "cashandcashequivalentsatcarryingvalue": "null",
    "prepaidexpenseandotherassetscurrent": 825134,
    "assetscurrent": "null",
    "assets": 11623940,
    "accountspayablecurrent": 515245,
    "otheraccruedliabilitiescurrent": "null",
    "liabilitiescurrent": "null",
    "liabilities": "null",
    "commonstockvalue": 833,
    "additionalpaidincapital": "null",
    "retainedearningsaccumulateddeficit": "-null",
    "stockholdersequity": "-null",
    "liabilitiesandstockholdersequity": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": "null",
    "generalandadministrativeexpense": "null",
    "operatingcostsandexpenses": "null",
    "operatingincomeloss": "-null",
    "interestexpense": 45613,
    "netincomeloss": "-null",
    "deemeddividendupontheredemptionofpreferredstock": 269038,
    "preferredstockdividendsincomestatementimpact": "null",
    "netincomelossavailabletocommonstockholdersbasic": "-null",
    "earningspersharebasic": -2.43,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "sharesissued": "null",
    "series1dpreferredunitsissuedshares": "null",
    "series1dpreferredunitsissuedamount": "null",
    "classbcommonunitsforfeitedshares": -22494,
    "conversionofcommonunitstocommonstockshares": "null",
    "conversionofcommonunitstocommonstockamount": 191,
    "conversionofpreferredunitstopreferredstockshares": "null",
    "conversionofpreferredunitstopreferredstockamount": "null",
    "conversionofwarrantunitstopreferredstockshares": "null",
    "conversionofwarrantunitstopreferredstockamount": 723289,
    "redemptionofseries1cpreferredsharesshares": "-null",
    "redemptionofseries1cpreferredsharesamount": -999478,
    "conversionofpreferredstocktocommonstockshares": "null",
    "conversionofpreferredstocktocommonstockamount": 6200,
    "conversionofpreferredstockwarrantstocommonstockwarrantsshares": "-null",
    "conversionofpreferredstockwarrantstocommonstockwarrantsamount": -142,
    "conversionofconvertibledebttocommonstockshares": 32219,
    "conversionofconvertibledebttocommonstockamount": 180434,
    "issuanceofcommonstockandwarrantsnetissuancecostsshares": "null",
    "issuanceofcommonstockandwarrantsnetissuancecostsamount": "null",
    "stockgrantedduringperiodvaluesharebasedcompensation": "null",
    "sharebasedcompensation": "null",
    "amortizationofdebtdiscountpremium": 16888,
    "increasedecreaseinprepaidexpense": -750081,
    "increasedecreaseinaccountspayable": 410969,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 628663,
    "increasedecreaseinlicenseandsettlementagreement": "-",
    "netcashprovidedbyusedincontinuingoperations": "null",
    "netcashprovidedbyusedinoperatingactivities": "-null",
    "proceedsfromissuanceofcommonstockandwarrantsnetofissuancecosts": "null",
    "redemptionofseries1cpreferredstock": "null",
    "proceedsfromrepaymentsofnotespayable": -556482,
    "proceedsfromconvertibledebt": "null",
    "proceedsfromissuanceofseries1dpreferredunits": 570000,
    "netcashprovidedbyusedinfinancingactivities": "null",
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": "null",
    "cash": 10798806,
    "interestpaid": 1420,
    "incometaxespaid": 1400,
    "conversionofcommonandpreferredunitsandwarrantstocommonandpreferredstockandwarrants": "null",
    "conversionofconvertiblesubordinatedpromissorynotestoseries1dpreferredunits": "null",
    "interestexpensesubordinatednotesanddebentures": 180434,
    "conversionofstockamountconverted1": 6582,
    "accumulateddeficit": -36000000,
    "netcashprovidedbyusedindiscontinuedoperations": 5700000,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 20.5,
    "paymentsofdividendscommonstock": 269038,
    "commonstockoptions": 523199,
    "commonstockwarrants": "null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "deferredofferingcosts": 55718,
    "deferredfinancecostsnet": 60000,
    "prepaidinsurance": 769416,
    "prepaidexpensecurrent": 825134,
    "accruedresearchanddevelopmentcosts": 235384,
    "accruedcompensationandbenefits": 766207,
    "otheraccruedliabilitiesnoncurrent": "null",
    "numberofoptionsoutstandingoptionsgranted": 523199,
    "numberofoptionsoutstandingendingbalance": 523199,
    "numberofoptionsoutstandingoptionsexercisable": 263720,
    "weightedaverageexercisepriceoptionsgranted": 5.84,
    "weightedaverageexercisepriceendingbalance": 5.84,
    "weightedaverageexercisepriceoptionsexercisable": 5.83,
    "weightedaverageremainingcontractualterminyearsbeginningbalance": "-",
    "weightedaverageremainingcontractualterminyearsoptionsgranted": 8.8,
    "weightedaverageremainingcontractualterminyearsoptionsexercised": "-",
    "weightedaverageremainingcontractualterminyearsoptionscancelled": "-",
    "weightedaverageremainingcontractualterminyearsendingbalance": 8.8,
    "weightedaverageremainingcontractualterminyearsoptionsexercisable": 9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 4.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0092,
    "sharebasedcompensationarrangementbysharebasedpaymentawardtermsofaward": 5.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.22,
    "otherresearchanddevelopmentexpense": 354201,
    "othergeneralandadministrativeexpense": "null",
    "unrecognizedfuturestockbasedcompensationexpense": 1200000,
    "expectedlenghtofrecognizedterm": 2.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": 10,
    "stockawardsgrantedvestingperiod": "four years for employees and one year for directors of the Company’s board and consultants",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "commonstocktradedprice": 1.74,
    "additionalresearchanddevelopmentexpense": 2100000,
    "debtconversionconvertedinstrumentamount1": 2300000,
    "dividendspreferredstockd4": 1200000,
    "convertiblepreferredstockconvertedtoothersecurities": "null",
    "commonstockshareissued": "null",
    "outstandingwarrantsexercisable": "null",
    "warrantsfairvaluepershare": 1.74,
    "classofwarrantorrightoutstanding": 69212,
    "warrantsexpiredate": "August 17, 2026",
    "debtinstrumentconvertibleconversionprice1": 0.8,
    "preferredunitinterestrate": 8,
    "percentagesofinitialpublicpershareofferingprice": 0.8,
    "dividendspreferredstockstock": 269038,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -1659000,
    "incometaxreconciliationpermanentandotherdifference": 38000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 110000,
    "incometaxreconciliationtaxescreditsresearch": -118000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 1629000,
    "deferredtaxassetsoperatinglosscarryforwards": 1049000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 30000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 274000,
    "deferredtaxassetsgoodwillandintangibleassets": 110000,
    "deferredtaxassetsother": 78000,
    "deferredtaxassetsgross": 1629000,
    "deferredtaxassetsvaluationallowance": 1629000,
    "unrecognizedtaxbenefits": 41000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 41000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 5000000,
    "netoperatinglosscarryforwardstaxableincomeoffsetlimitpercentage": 0.8,
    "valuationallowance": 1600000,
    "taxcreditcarryforwardexpirationyear": 2041
  }
]